Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery · 2004
Histological investigation of osteoinductive properties of rh-BMP2 in a rat calvarial bone defect model.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Inoda Hirosato, Yamamoto Gaku, Hattori Takanori
Аннотация
INTRODUCTION: Recombinant human bone morphogenetic protein-2 (rh-BMP2) has osteoinductive properties. The sequence of osteogenesis induced by rh-BMP2 in a rat calvarial bone defect model was evaluated histologically.
MATERIAL AND METHODS: Atelopeptide type I collagen was selected as the carrier matrix for rh-BMP2. This collagen was mixed with 50 microg of rh-BMP2 and treated by lyophilization to make a suitable form for filling bone defects. Thirty Wistar rats (male; 10 weeks old) underwent craniotomy resulting in a round bone defect with a diameter of 4 mm. Three weeks after the operation, the defect site was exposed to implant collagen with rh-BMP2 in the experimental group and collagen only in the control group. Three, 6 and 9 weeks after implantation, calvarial specimens were harvested and stained with haematoxylin/eosin. In addition, bromodeoxyuridine (BrdU) immunohistochemical staining was performed.
RESULTS: In the experimental group, marked ossification was found. In contrast, there was no tendency towards osteogenesis in the control group, 9 weeks after collagen implantation. In BrdU immunohistochemical staining, the number of BrdU-positive cells was significantly higher in the experimental group than in the control group, and was significantly higher at the periosteal site than at other sites at 3 and 6 weeks after implantation.
CONCLUSIONS: rh-BMP2 exhibited osteoinductive properties, and markedly stimulated proliferation of periosteal cells.
MATERIAL AND METHODS: Atelopeptide type I collagen was selected as the carrier matrix for rh-BMP2. This collagen was mixed with 50 microg of rh-BMP2 and treated by lyophilization to make a suitable form for filling bone defects. Thirty Wistar rats (male; 10 weeks old) underwent craniotomy resulting in a round bone defect with a diameter of 4 mm. Three weeks after the operation, the defect site was exposed to implant collagen with rh-BMP2 in the experimental group and collagen only in the control group. Three, 6 and 9 weeks after implantation, calvarial specimens were harvested and stained with haematoxylin/eosin. In addition, bromodeoxyuridine (BrdU) immunohistochemical staining was performed.
RESULTS: In the experimental group, marked ossification was found. In contrast, there was no tendency towards osteogenesis in the control group, 9 weeks after collagen implantation. In BrdU immunohistochemical staining, the number of BrdU-positive cells was significantly higher in the experimental group than in the control group, and was significantly higher at the periosteal site than at other sites at 3 and 6 weeks after implantation.
CONCLUSIONS: rh-BMP2 exhibited osteoinductive properties, and markedly stimulated proliferation of periosteal cells.
Предметные рубрики MeSH
AnimalsAntimetabolitesBone DiseasesBone Morphogenetic Protein 2Bone Morphogenetic ProteinsBromodeoxyuridineCell ProliferationCollagenColoring AgentsDisease Models, AnimalDrug CarriersEosine Yellowish-(YS)Fluorescent DyesHematoxylinHumansMaleOsteogenesisPeriosteumRatsRats, WistarRecombinant ProteinsSkullTime FactorsTransforming Growth Factor beta